|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/10 | |
| A61K 31/282 | |||
| A61K 31/337 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2841084 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13727657.2 |
| Europos patento paraiškos padavimo data | 2013-04-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2013/050352 |
| Data | 2013-04-24 |
| (87) | Numeris | WO 2013/160895 |
| Data | 2013-10-31 |
| (30) | Numeris | Data | Šalis |
| 201261637334 P | 2012-04-24 | US |
| (72) |
PELED, Amnon, IL
WALD, Ori, IL
|
| (73) |
Biokine Therapeutics Ltd.,
Building 13a Einstein Street, Science Park Kiryat Weizmann, 70400 Nes Ziona,
IL
|
| (54) | CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER |
| CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER |